ConductScience.org, home

Paper42447166

Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence.

Pérez Molina CJ and 2 others. PLoS One, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence. Papers, record 42447166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42447166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence.
PubMed
Journal
PLoS One
PubMed
Year
2026
PubMed
Publication types
Journal Article, Scoping Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pérez Molina CJClímaco de Jesúshttps://orcid.org/0000-0003-4630-4272
2Chavarro Bermeo FEFlor Elena
3Pérez Hernández AMBArlin Martha Bibiana

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Yellow FeverMajor topic
Yellow Fever VaccineMajor topic
ImmunomodulationMajor topic
Humans
Latin America
Vaccination
Disease Outbreaks

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124006295Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.Am J Trop Med Hyg2013https://conductscience.org/library/papers/24006295PubMed
211871403Yellow fever: an update.Lancet Infect Dis2001https://conductscience.org/library/papers/11871403PubMed
321109907Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas.Rev Saude Publica2010https://conductscience.org/library/papers/21109907PubMed
430139914The reemergence of yellow fever.Science2018https://conductscience.org/library/papers/30139914PubMed
523909008Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.Wkly Epidemiol Rec2013https://conductscience.org/library/papers/23909008PubMed
630178033PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.Ann Intern Med2018https://conductscience.org/library/papers/30178033PubMed
725453327Yellow fever.J Clin Virol2015https://conductscience.org/library/papers/25453327PubMed
82336447217DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23364472PubMed
920463105Correlates of protection induced by vaccination.Clin Vaccine Immunol2010https://conductscience.org/library/papers/20463105PubMed
1018809449Adverse event reports following yellow fever vaccination.Vaccine2008https://conductscience.org/library/papers/18809449PubMed
1122535696Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios.J R Soc Interface2012https://conductscience.org/library/papers/22535696PubMed
1214689698Pathogenesis and pathophysiology of yellow fever.Adv Virus Res2003https://conductscience.org/library/papers/14689698PubMed
1318847312Yellow fever vaccine: past, present and future.Expert Opin Biol Ther2008https://conductscience.org/library/papers/18847312PubMed
1433422247Public health role for fractional dosage of yellow fever vaccine.Lancet2021https://conductscience.org/library/papers/33422247PubMed
1530427974Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation.Mem Inst Oswaldo Cruz2018https://conductscience.org/library/papers/30427974PubMed
1624079979Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review.Vaccine2013https://conductscience.org/library/papers/24079979PubMed
1725713354Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25713354PubMed
1818728272Yellow fever: 100 years of discovery.JAMA2008https://conductscience.org/library/papers/18728272PubMed
1931616412Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.Front Immunol2019https://conductscience.org/library/papers/31616412PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42447166

GET https://conductscience.org/api/papers/v1/42447166/authors